Marie-Joelle Jabagi

7PUBLICATIONS
14CO-AUTHORS
Consumer-oriented product or service developmentMedical infection agents (incl. prions)Nanotoxicology, health and safetyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 10, 2025
Use of Semaglutide (Wegovy) in Adults in France: A Nationwide Drug Utilization Study.

Nadia Haddy, Hugo Jourdain, David Desplas

|Sep 04, 2024
Influence of mRNA Covid-19 vaccine dosing interval on the risk of myocarditis.

Stéphane Le Vu, Marion Bertrand, Laura Semenzato

|Aug 22, 2022
Risk for Myocardial Infarction, Stroke, and Pulmonary Embolism Following COVID-19 Vaccines in Adults Younger Than 75 Years in France.

Jérémie Botton, Marie Joelle Jabagi, Marion Bertrand

|Jun 25, 2022
Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines.

Stéphane Le Vu, Marion Bertrand, Marie-Joelle Jabagi

|Jul 20, 2020
Risk of secondary hematologic malignancies associated with breast cancer chemotherapy and G-CSF support: A nationwide population-based cohort.

Marie Joelle Jabagi, Norbert Vey, Anthony Goncalves

Pageof 2